Skip to main content
. Author manuscript; available in PMC: 2015 Mar 20.
Published in final edited form as: Oncogene. 2013 Apr 22;33(12):1538–1547. doi: 10.1038/onc.2013.102

Table 1.

Tumor incidence in Control, Tgfbr2IEKO, PtenIEKO and PtenIEKO;Tgfbr2IEKO mice

Genotype Number of mice Number of mice with hyperplastic lesions Number of mice with adenocarcinomas Number of hyperplastic lesions Number of adenocarcinomas
Control# 20 0 0 0 0
Tgfbr2IEKO 20 0 0 0 0
PtenIEKO 39 2 1λ 3 1
PtenIEKO; Tgfbr2IEKO 43 4μ,£.¥ 35δ,&.¥ 4 49
#

Control = wild-type mice, matched strain background

P = 0.54, PtenIEKO (2/39) vs. Control (0/20), Fisher’s exact test

λ

P = 1.0, PtenIEKO (1/39) vs. Control (0/20), Fisher’s exact test

μ

P = 0.30, PtenIEKO; Tgfbr2IEKO (4/43) vs. Control (0/20), Fisher’s exact test

£

P = 0.68, PtenIEKO; Tgfbr2IEKO (4/43) vs. PtenIEKO (2/39), Fisher’s exact test

δ

P < 0.0001, PtenIEKO; Tgfbr2IEKO (35/43) vs. Control (0/20), Fisher’s exact test

&

P < 0.0001, PtenIEKO; Tgfbr2IEKO (35/43) vs. PtenIEKO (1/39), Fisher’s exact test

¥

N=2 mice developed one adenocarcinoma and one hyperplastic lesion with dysplasia